Table 2.
Demographic, clinical and genetic characteristics of previously reported patients
First Author | Age of onset, sex | Clinical manifestation | Genetic |
---|---|---|---|
Herrera-Olivares A.M.[10] | 23, F | Recurrent rhabdomyolysis | Compound heterozygous: c.589G>A (p.Val197Met) and c.1742T>C (p.lle581Thr) |
Hisahara, S.[11] | 17, M | Recurrent rhabdomyolysis | Heterozygous: missense mutation, c.1242G>C p.(Glu414Asp) in exon 12 with single nucleotide polymorphism: a C>T variation in intron 6. |
Voermans, N.C.[12] | 51, F | Exercise intolerance | Heterozygous: c.1322G>A p.(Gly441Asp). The second mutation may have been missed if it is located outside the examined region of the gene. |
Smelt AH.[25] | 40, F | Muscle pain and stiffness | Compound heterozygous: G>A; p.(Gly40lAsp) in exon 13 and G>A in exon 14 (p.(Arg410His) |
Stępień K.M.[14] | 17, F | Rhabdomyolysis | Homozygous: c.1106T>G; p.(Phe369Cys), in exon 11 |
Murata K.Y.[15] | 29, F | Exercise-induced muscle pain | Homozygous: c.272C>T; p.(Pro91Leu) |
Mendez-Figueroa H.[16] | 20, F | Recurrent episodes of muscle weakness, chronic myalgia, rhabdomyolysis | Compound heterozygous: c.848T>C (p.Val283Ala) and c.879–8T>A |
Voermans N.C.[17] | 20, M | Exercise-induced rhabdomyolysis | Heterozygous: c.848T>C p.(Val243Ala) and c.1322G>A; p.(Gly401Asp) |
Merinero B.[18] | 17, F | Exercise-induced muscle pain and myoglobinuria. | Compound heterozygous: c.1213G>C; p.(Asp365His) in exon 12 and c.1349G>A; p.(Arg410His) in exon 14. |